1. Aaron, HJ. Serious and unstable condition. Washington DC: The Brookings Institution; 1991.
2. Bodenheimer, T. High and rising health care costs. Part 2: Technologic innovation. Ann Inten Med. 2005;142:932–937.
3. Borowski, HZ, Brehaut, J, Hailey, D. Linking evidence from health technology assessments to policy and decision making: The Alberta model. Int J Technol Assess Health Care. 2007;23:155–161.
4. Chernew, ME, Hirth, RA, Sonnad, SS, Rrmann, R, Fendrick, AM. Managed care, medical technology, and health care cost growth: A review of the evidence. Med Care Res Rev. 1998;55:259–288.
5. Culyer, AJ. NICE's use of cost-effectiveness as an exemplar of a deliberative process. Health Econ Policy Law. 2006;1:299–318.
6. Daniels, N, Sabin, JE. Accountability for reasonableness. In: Daniels, N, Sabin, JE, eds. Setting limits fairly: Can we learn to share medical resources. New York: Oxford University Press; 2002:43–66.
7. Daniels, N, Sabin, JE. Accountability for reasonableness: An Update. BMJ. 2008;337:a1850.
8. Erickson, LJ, De Wals, P, Farand, L. An analytical framework for immunization programs in Canada. Vaccine. 2005;23:2470–2476.
9. Fuchs, VR, Sox, HC Jr. Physicians' views of the relative importance of thirty medical innovations. Health Aff (Milwood). 2001;20:30–42.
10. Garcia-Altes, A, Ondategui-Parra, S, Neumann, PJ. Cross-national comparison of technology assessment processes. Int J Technol Assess Health Care. 2004;20:300–310.
11. Gelijins, A, Rosenberg, N. The dynamics of technological change in medicine. Health Aff (Milwood). 1994;13:28–46.
12. Giacomini, M. One of these things is not like the others: The idea of precedence in health technology assessment and coverage decisions. Milbank Q. 2005;83:193–223.
13. Giacomini, M. How good is good enough? Standards in policy decisions to cover new health technologies. Healthc Policy. 2007;3:91–101.
14. Johnson-Masotti, AP, Eva, K. A Decision-making framework for the prioritization of health technologies. In: Beach, CM, Chaykowski, S, Shortt, S, St.-Hilaire, F, Sweetman, A, eds. Health services restructuring in Canada: New evidence and new directions. Kingston: John Deutsch Institute, Queen's University; 2006:59–81.
15. Lehoux, P, Williams-Jones, B. Mapping the integration of social and ethical issues in health technology assessment. Int J Technol Assess Health Care. 2007;23:9–16.
16. Levin, L, Goeree, R, Sikich, N et al., Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: The Ontario experience. Int J Technol Assess Health Care. 2007;23:299–309.
17. National Institute for Clinical Excellence TAT. Parallel sessions: NICE work. Technology appraisal guidance: An overview. J Clin Excell. 2002;4:350–351.
18. Neumann, PJ, Palmer, MS, Daniels, N et al. , A strategic plan for integrating cost-effectiveness analysis into the US healthcare system. Am J Manag Care. 2008;14:185–188.
19. Newhouse, JP. An iconoclastic view of health cost containment. Health Aff (Milwood). 1993;14:185–188.
20. Noorani, HZ, Husereau, DR, Boudreau, R, Skidmore, B. Priority setting for health technology assessments: A systematic review of current practical approaches. Int J Technol Assess Health Care. 2007;23:310–315.
21. PausJenssen, AM, Singer, PA, Detsdu, AS. Ontario's formulary committee: How recommendations are made. Pharmacoeconomics. 2003;21:285–294.
22. Rawlins, MD. NICE work – providing guidance to the British National Health Service. N Engl J Med. 2004;351:1383–1385.
23. Royle, P, Waugh, N. Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institutes for Clinical Excellence appraisal system. Health Technol Assess. 2003;7 (iii, ix–x):1–51.
24. Sackett, DL, Rosenberg, WMC, Gray, JAM, Haynes, RB, Richardson, WS. Evidence based medicine: What it is and what it isn't. BMJ. 1996;312:71–72.
25. Visalakshi, S, Mohan, S. Evaluation of biotechnology-based healthcare products for prioritization in Indian context. Int J Technol Assess Health Care. 2002;18:718–227.